Evidence map›Paper›PMID 33570093›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2021

Hyperactive MEK1 Signaling in Cortical GABAergic Neurons Promotes Embryonic Parvalbumin Neuron Loss and Defects in Behavioral Inhibition.

Michael C Holter, Lauren T Hewitt, Kenji J Nishimura, Sara J Knowles, George R Bjorklund, Shiv Shah, Noah R Fry, Katherina P Rees, Tanya A Gupta, Carter W Daniels and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Michael C HolterSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Lauren T HewittSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Kenji J NishimuraSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Sara J KnowlesSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0003-3906-8195
George R BjorklundSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Shiv ShahSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Noah R FrySchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Katherina P ReesSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Tanya A GuptaDepartment of Psychology, Arizona State University, Tempe, AZ 85287, USA.
Carter W DanielsDepartment of Psychology, Arizona State University, Tempe, AZ 85287, USA.
Guohui LiCollege of Medicine, University of Arizona, Phoenix, AZ 85004, USA.
Steven MarshBarrow Neurological Institute, Phoenix, AZ 85013, USA.
David Michael TreimanBarrow Neurological Institute, Phoenix, AZ 85013, USA.
Michael Foster OliveDepartment of Psychology, Arizona State University, Tempe, AZ 85287, USA.
Trent R AndersonCollege of Medicine, University of Arizona, Phoenix, AZ 85004, USA.
Federico SanabriaDepartment of Psychology, Arizona State University, Tempe, AZ 85287, USA.
William D SniderUniversity of North Carolina Neuroscience Center, The University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Jason M NewbernSchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0003-2865-0112
Arizona State University · USBarrow Neurological Institute · USUniversity of Arizona · USUniversity of North Carolina at Chapel Hill · US

Funding

Roles of Growth Factor Signaling in Neural RegenerationR01NS031768 · NINDS · WASHINGTON UNIVERSITY · PI SNIDER, WILLIAM D · 1993 to 2016
$6.7M
Functions of ERK/MAPK Signaling in GABAergic Circuit DevelopmentR01NS097537 · NINDS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI NEWBERN, JASON MARSHALL · 2016 to 2020
$1.7M
ERK/MAPK regulation of cortical inhibitory interneuronsR00NS076661 · NINDS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI NEWBERN, JASON MARSHALL · 2013 to 2015
$726k
ERK/MAPK regulation of cortical inhibitory interneuronsK99NS076661 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NEWBERN, JASON MARSHALL · 2011 to 2012
$174k
NINDS NIH HHS K99 NS076661NINDS NIH HHS R00 NS076661NINDS NIH HHS R01 NS031768NINDS NIH HHS R01 NS097537
6 · The paper itself

Abstract

Many developmental syndromes have been linked to genetic mutations that cause abnormal ERK/MAPK activity; however, the neuropathological effects of hyperactive signaling are not fully understood. Here, we examined whether hyperactivation of MEK1 modifies the development of GABAergic cortical interneurons (CINs), a heterogeneous population of inhibitory neurons necessary for cortical function. We show that GABAergic-neuron specific MEK1 hyperactivation in vivo leads to increased cleaved caspase-3 labeling in a subpopulation of immature neurons in the embryonic subpallial mantle zone. Adult mutants displayed a significant loss of parvalbumin (PV), but not somatostatin, expressing CINs and a reduction in perisomatic inhibitory synapses on excitatory neurons. Surviving mutant PV-CINs maintained a typical fast-spiking phenotype but showed signs of decreased intrinsic excitability that coincided with an increased risk of seizure-like phenotypes. In contrast to other mouse models of PV-CIN loss, we discovered a robust increase in the accumulation of perineuronal nets, an extracellular structure thought to restrict plasticity. Indeed, we found that mutants exhibited a significant impairment in the acquisition of behavioral response inhibition capacity. Overall, our data suggest PV-CIN development is particularly sensitive to hyperactive MEK1 signaling, which may underlie certain neurological deficits frequently observed in ERK/MAPK-linked syndromes.

Indexed as

Inhibition, PsychologicalAnimalsCerebral CortexElectroencephalographyEmbryonic DevelopmentGABAergic NeuronsLocomotionMAP Kinase Kinase 1MiceOrgan Culture TechniquesParvalbuminsSignal TransductionMap2k1 protein, mouseMAP Kinase Kinase 1ParvalbuminsADHDdevelopmentERK1/2ganglionic eminenceRASopathy

Identifiers

PMID33570093
PMCPMC8325019
OpenAlexW3128011872

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.